We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
701
DELISTED
ZENDESK INC
ZEN
| $1.13M | 0.01% |
+36,647
| New | +$1.09M |
|
|
THS
702
DELISTED
Treehouse Foods
THS
| $1.12M | 0.01% |
12,861
-10,889
| -46% | -$1.05M |
|
|
FGL
703
DELISTED
Fidelity & Guaranty Life
FGL
| $1.08M | 0.01% |
46,805
-32,172
| -41% | -$739K |
|
|
ESRX
704
DELISTED
Express Scripts Holding Company
ESRX
| $1.08M | 0.01% |
15,254
-12,617
| -45% | -$944K |
|
|
TWOU
705
DELISTED
2U Inc
TWOU
| $1.07M | 0.01% |
931
-3,594
| -79% | -$3.75M |
|
706
Outlook Therapeutics
OTLK
$264M
| $1.06M | 0.01% |
1,564
| – | – |
|
|
BHI
707
DELISTED
Baker Hughes
BHI
| $1.06M | 0.01% |
20,933
-78,562
| -79% | -$3.78M |
|
708
Lear
LEA
$7.19B
| $1.06M | 0.01% |
+8,710
| New | +$992K |
|
709
Advanced Drainage Systems
WMS
$10.9B
| $1.05M | 0.01% |
+43,671
| New | +$1.11M |
|
|
RTEC
710
DELISTED
Rudolph Technologies Inc
RTEC
| $1.05M | 0.01% |
59,023
+34,082
| +137% | +$578K |
|
711
Graco
GGG
$12.9B
| $1.04M | 0.01% |
+42,222
| New | +$1.06M |
|
|
ZIXI
712
DELISTED
Zix Corporation
ZIXI
| $1.04M | 0.01% |
+254,258
| New | +$1M |
|
713
CF Industries
CF
$19.2B
| $1.03M | 0.01% |
42,263
-72,680
| -63% | -$1.77M |
|
|
VTAE
714
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $1.03M | 0.01% |
49,146
-69,809
| -59% | -$804K |
|
715
Lamar Advertising Co
LAMR
$16.2B
| $1.02M | 0.01% |
+15,638
| New | +$1.01M |
|
|
CSOD
716
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.02M | 0.01% |
+22,145
| New | +$970K |
|
717
CoStar Group
CSGP
$11.3B
| $1.01M | 0.01% |
+46,800
| New | +$996K |
|
718
CarMax
KMX
$8.27B
| $1M | 0.01% |
+18,803
| New | +$1.07M |
|
719
Oil States International
OIS
$522M
| $992K | 0.01% |
+31,423
| New | +$966K |
|
|
CRR
720
DELISTED
Carbo Ceramics Inc.
CRR
| $989K | 0.01% |
90,472
+68,906
| +320% | +$885K |
|
721
Applied Materials
AMAT
$426B
| $986K | 0.01% |
32,693
-21,687
| -40% | -$605K |
|
|
AM
722
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $978K | 0.01% |
+36,624
| New | +$972K |
|
723
DHT Holdings
DHT
$2.97B
| $975K | 0.01% |
232,711
-1,233,911
| -84% | -$5.74M |
|
724
Medpace
MEDP
$16.8B
| $969K | 0.01% |
+32,465
| New | +$948K |
|
|
GK
725
DELISTED
G&K Services Inc
GK
| $966K | 0.01% |
10,112
-5,783
| -36% | -$512K |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.